HAIFA, Israel--(BUSINESS WIRE)--Aug. 24, 2006--Pluristem Life Systems, Inc. (OTCBB:PLRS) announces that its fully owned subsidiary Pluristem Ltd received a $470,000 grant from Israel’s prestigious Chief Scientist Office (CSO). The royalty-bearing grant is part of the Government’s Ministry of Trade and Industry program that offers incentives to high-tech companies for capital investment, scientific research and development. The monies were designated by the Chief Scientist Office to further develop first-time-recipient Pluristem’s stem cell product PLX-I, a breakthrough potential solution that could be used to replace the traditional bone marrow transplant search and match process.
